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Abstract
Many biochemical and biophysical analyses of enzymes require quantities of
protein that are difficult to obtain from expression in an endogenous system. To
further complicate matters, native adenosine deaminases that act on RNA
(ADARs) are expressed at very low levels, and overexpression of active protein
has been unsuccessful in common bacterial systems. Here we describe the
plasmid construction, expression, and purification procedures for ADARs over-
expressedintheyeastSaccharomycescerevisiae.ADARexpressioniscontrolled
by the Gal promoter, which allows for rapid induction of transcription when the
yeast are grown in media containing galactose. The ADAR is translated with an
N-terminal histidine tag that is cleaved by the tobacco etch virus protease,
generatingonenonnativeglycineresidueattheN-terminus oftheADARprotein.
ADARs expressed using this system can be purified to homogeneity, are highly
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319active in deaminating RNA, and are produced in quantities (from 3 to 10 mg of
pure protein per liter of yeast culture) that are sufficient for most biophysical
studies.
1. Introduction
Adenosinedeaminasesthatact onRNA(ADARs)convert adenosineto
inosine in regions of RNA that are largely double stranded (Bass, 2002;
Keeganet al.,2004;ValenteandNishikura,2005).Sinceinosineisrecognized
as guanosine, the result of editing by an ADAR is an A-to-G transition
mutation. ADARs are found in every metazoan animal (not plants) and are
essentialforproperneuronal function. Thisissupportedbyevidenceshowing
that knockouts of ADARs lead to various behavioral abnormalities (Higuchi
etal.,2000;Palladinoetal.,2000a;Tonkinetal.,20 02)andthatseveralknown
pre-mRNA substrates code for neuronal receptors and ion channels (Burns
et al., 1997; Higuchi et al., 1993; Lomeli et al., 1994). Though the effects of
editing coding sequences are dramatic, these editing events are rare relative to
the levels of editing in noncoding regions, especially untranslated regions
(UTRs) (Blow et al., 2004; Levanon et al., 2004; Morse and Bass, 1999;
Morse et al.,2 0 0 2 ). The extensive editing of noncoding regions has been
proposed to affect expression of a gene posttranscriptionally, although how
this might occur is unclear. Editing of double-stranded RNAs, such as those
regions found in UTRs, creates I-to-U mismatches from A-to-U base pairs,
and results in an RNA that is less double stranded. Although the biological
consequences are not yet understood, an RNA made more single stranded by
A-to-I modification can affect recognition by the RNAi machinery (Knight
and Bass, 2002; Scadden and Smith, 2001).
ADARs are composed of an N-terminal RNA-binding domain and a
C-terminal catalytic domain. The RNA-binding domain consists of one to
three double-stranded RNA-binding motifs (dsRBM). The catalytic domain
consists of a deaminase motif that resembles Escherichia coli cytidine deaminase
and binds zinc, as well as a motif that coordinates the small molecule myo-
inositol hexakisphosphate (IP6, Maas et al., 2003; Macbeth et al., 2005).
In addition, human and Xenopus ADAR1 contain two Z-DNA-binding
motifs N-terminal to their three dsRBMs (Maas et al., 2003). ADARs are
modular, and for hADAR2, the isolated dsRBMs will each bind RNA in the
absence of the catalytic domain. Further, the catalytic domain will deaminate
dsRNA in the absence of the dsRBMs, albeit poorly.
As the number of ADAR enzymes and substrates from various species
rapidly increased over the past several years (Chen et al., 2000; Palladino
et al., 2000b; Patton et al., 1997; Tonkin et al., 2002), it became apparent
that our understanding of ADAR biochemistry was struggling to keep pace.
There are several reasons for this, the most prominent being a dearth of
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low amounts of protein (Hough and Bass, 1994; O’Connell and Keller,
1994; O’Connell et al., 1997). Indeed, the initial purification of Xenopus
ADAR yielded only a few micrograms from over 4 liters of eggs (Hough
and Bass, 1994).
Various expression systems have been employed to increase the yield and
specific activity of ADAR proteins. Standard E. coli overexpression systems
are useful for expressing the dsRBMs, but constructs that contain the
catalytic domain are largely insoluble; any soluble protein (typically <1%)
lacks deaminase activity (M. R. Macbeth and B. L. Bass, unpublished
observations). The reason for this is unclear, but might be explained by
the lack of IP6 in E. coli, which is required for ADAR editing activity and
perhaps proper folding. Eukaryotic expression systems such as Pichia pastoris
and insect cell culture harboring baculovirus have been utilized with good
results (Cho et al., 2003; Ring et al., 2004). However, each of these systems
has its drawbacks. For the Pichia system, induction times are several days,
and, in our experience, yields are low. We believe the poor yield is due to
the toxic nature of ADAR overexpression, which may lead to downregula-
tion. Thebaculovirus–insect cell systemistedious andrequirestissue culture
facilities and expensive media.
We have achieved good success using a Saccharomyces cerevisiae over-
expression system for generating full-length and truncated ADAR proteins
that contain the catalytic domain. There are many benefits to using this
system: (1) There is a short ( 6 h) induction time that is beneficial if the
enzymes are unstable or toxic. (2) The yeasts are easy to genetically manipu-
late, which allows studying the effects of other factors (i.e., IP6)o nA D A R
function. (3) There is no contamination from native editing activity, as
S. cerevisiae does not encode an ADAR. (4) The medium is relatively
inexpensive.
The ADAR proteins expressed in this system are produced in substantial
quantities, are highly active, and are >99% pure. They have been used for
several biophysical and biochemical assays including equilibrium sedimen-
tation, dynamic light scattering, gel shift analyses, RNA editing, and X-ray
crystallography (Macbeth et al., 2004, 2005). The details of the expression
and purification, as well as some of the protein analyses, are discussed in
Chapter 16.
2. Methods
2.1. General considerations
Unless stated otherwise, all media and chemicals are from Sigma-Aldrich.
Large-scale yeast expression cultures are grown at 30  using a 15-liter Bellco
bioreactor that allows for stable regulation of oxygen levels at 22%. All media
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tures can be grown in shaker flasks with proportionate amounts of media
components; however, expect disproportionately less cell mass and purified
protein, an effect, we believe, that is due to unregulated air/O2 levels. Before
attempting a large-scale preparation, it is prudent to perform a small-scale
growth(50–100 mlcultures)andtestforexpressionbyWesternblottingusing
an appropriate antibody.
All purification steps are performed at 4  or on ice, and after each step
the protein is analyzed by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS–PAGE). Many of the purification steps described here use
a pump-driven AKTA system (GE Healthcare); however, many columns
can be eluted using gravity flow or a peristaltic pump. It is imperative that
the time from cell lysis to protein storage be minimized for the highest
specific activity of the enzyme.
2.2. Expression constructs and yeast strains
The vector used for overexpression of ADARs is based on the YEpTOP2P-
GAL1 vector used to express DNA topoisomerase (Giaever et al., 1988).
The vector has a pBR322 backbone and contains a URA3 gene, a 2 mm
origin of replication, an ampicillin resistance marker, and a GAL1 promoter
immediately upstream of the BamHI (50) cloning site (Fig. 15.1A). If the
ADAR gene contains a BamHI or XhoI site, several other restriction
enzymes are available that will cleave different recognition sites yet leave
BamHI and XhoI compatible ends. We have successfully used BsmBI (New
England Biolabs) for this purpose.
The ADAR insert construct generated by polymerase chain reaction
(PCR) consists of an N-terminal 10-histidine tag followed by a tobacco
etch virus (TEV) protease recognition site (Fig. 15.1B). The 50 end of
the PCR product is of the sequence GGGGGG GGATCC GTAACC
ATGTCA (CACCAT)5 GAGAACCTCTATTTCCAGGGA (X)20. The
first six nucleotides provide space from the DNA end for the BamHI
recognition site (which is the second six nucleotides). The GTAACC
sequence allows for efficient translation initiation, and it is followed by
the initiator methionine codon (ATG) and a þ2 serine codon (TCA)
that also promote efficient translation. A 10 -histidine coding sequence,
(CACCAT)5, is followed by a sequence that codes for TEV protease recog-
nition, and the remaining  20 nucleotides (X) code for the N-terminus of
the ADAR gene of interest. Note that after cleavage of the His-tag with
TEV, the protein will contain an N-terminal glycine, a remnant of the TEV
recognition site, prior to the start of the ADAR sequence. A primer that
encodes this entire sequence is exceptionally long, and we have found that
splitting the primer in half and performing tandem PCR led to more
efficient cloning. For example, the first round of PCR would incorporate
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round would incorporate the restriction site, start codon, and histidine tag.
The 30 primer is of the sequence GGGGGG CTCGAGTCA (X)20. The six
Gs provide a spacer from the end of the DNA for XhoI site recognition, and
this is followed by a stop codon and 20 (X) of the 30 residues of the ADAR
gene of interest.
After PCR, the ends of the insert product are trimmed with BamHI and
XhoIandinsertedintoavectorlinearizedwiththesameenzymes.Theinsertin
the resulting plasmid should be sequenced entirely using primers internal to
the subcloned ADAR gene. The expression plasmid is then transformed, by
electroporation or lithium acetate, into the haploid (type a) yeast strain
BCY123, which has the genotype pep4::HIS3 prb::LEU2 bar1:HISG lys2::
GAL1/10-GAL4can1ade2ura3leu2–3,112.Thisstrain hasseveraldefective
A
Ori
URA3
pSc-ADAR
ADAR
BamHI Xhol
2m
AmpR
PGAL1
B Start
BamHI
His-TEV ADAR ADAR
Stop
Xhol
GG G G G G GGG G.... AA A A A A A A A AA A A A TT T T T TT T T T T CC C C C CC CC C CC C () 5
MS H ( ×10) E N L Y F Q G M...
TEV site
Figure 15.1 The expression vector and 50 sequence of the construct used to tag and
purify ADARs. (A) The pSc-ADAR plasmid. The empty vector (lacking an ADAR
gene) is approximately 8 kb. The BamHI and XhoI restriction sites are unique in the
empty vector. Transcription of the ADAR gene is controlled by the GAL1 promoter
(indicated by the arrow). (B) A schematic of the ADAR construct after PCR of an
ADAR gene using the 50 primers described in the text.The translation start and stop
sites are indicated. Below the schematic are the DNA and translated protein sequences.
Note that aftercleavage withTEVprotease, there is a glycine residue N-terminaltothe
firstmethionineoftheADARproteinofinterest.
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Gal4 transcriptional activator during induction with galactose.
2.3. Yeast growth
After transformation, the yeasts are plated on agar plates containing
1  minimal media without uracil [6.7 g/liter yeast nitrogen base containing
(NH4)2SO4andlackingaminoacids(Fisher),10 g/litersuccinicacid,6 g/liter
NaOH,1.92 g/literyeastsyntheticdropoutmediawithouturacil,22 mg/liter
adenine hemisulfate] supplemented with 1 M sorbitol and 2% dextrose.
Colonies take 2–3 days to appear. We have found it beneficial to transform
the expression plasmid freshly, prior to attempting a large-scale growth, and
avoidusingglycerolstocksofyeastharboringtheplasmid.Asmentioned,prior
to attempting a large-scale growth for ADAR expression, small-scale cultures
should be used to test for expression of the ADAR.
The cells are grown in three stages in which the expression of the
ADAR gene is repressed, derepressed, or activated. In the repressed state,
the cells are grown in the presence of dextrose (glucose) in the starter
culture. The cells are then switched to a media containing glycerol and
lactic acid. The dextrose is depleted, and the gene is then ready for induc-
tion by the additionof galactose, which activates transcription of the ADAR
gene from the GAL1 promoter.
For ADAR expression, a 10 ml starter culture consisting of 1  minimal
mediawithout uracil supplemented with2% dextroseis inoculated withone
colony and grown overnight at 30  while shaking at 300 rpm. The follow-
ing morning, the entire culture is used to inoculate 200 ml of the same
media. After 24 h, the 200 ml culture is aseptically pumped into a 15-liter
Bellco bioreactor vessel containing 13.5 liters 1  minimal media without
uracil and 2% glycerol/3% lactic acid as the carbon source. The oxygen
levels are calibrated according to the manufacturer’s instructions, set at 22%,
and the culture is grown at 30  with vigorous stirring. After 24 h, the
culture is induced by the addition of 1.5 liter of 2  minimal media and
1.5 liter 30% galactose (final concentration of 2.7%). The final volume of
the culture is 16.5 liters. Induction is for 5–8 h, but should be optimized for
each construct by performing a time course and measuring protein produc-
tion by Western blotting. The cells are harvested by centrifugation at
6000 rpm for 5 min in a Beckman JA-20 centrifuge equipped with a JLA
8.100 6L fixed-angle rotor. The cells are washed in a solution containing
20 mM Tris–HCl, 100 mM NaCl, 5% glycerol, 25 mM NaF, 1 mM sodium
bisulfite and then centrifuged again. The wet mass of the cell pellet is
determined prior to storage at  80 . The typical yield is approximately
10–12 g wet cells/liter of culture. To test for expression, we routinely lyse
0.1 g of cells by vortexing with glass beads for 30 min at 4  in 500 mlo fa
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dithiothreitol (DTT), and 0.01% Triton X-100. The lysate is clarified by
centrifugation at 14,000 rpm in a microfuge, and expressed proteins are
detected by western blotting using the Penta-His antibody (Qiagen).
2.4. Purification
Typically, cells from 2.75 liters of the culture ( 25–30 g) will yield enough
pureproteinformost applications, includingX-ray crystallography, while the
remainder of the cells can be stored at  80  indefinitely. The cells are
resuspended in Buffer A (20 mM Tris–HCl, pH 8.0, 5% glycerol, 1 mM
2-mercaptoethanol) containing 750 mM NaCl, 35 mM imidazole, and
0.01% Triton X-100.1 The cells are lysed by three passes through a Gaulin
homogenizer (APV) at 20,000 psi2 and the extract is clarified by centrifugation
at100,000 gfor1 h.Thesupernatantismixedwith5 mlofNi-NTAagarose
(Qiagen) equilibrated with the same buffer used to lyse the cells. The slurry is
gently rocked at 4  for 15 min and poured into a 2.5   20-cm column,
while collecting the flowthrough by gravity. The washes are performed in
four40-mlsteps:thefirstiswiththesamebufferusedtolysethecells;thethree
subsequent washes use Buffer A containing 35 mM imidazole and either
750 mM, 300 mM, or 100 mM NaCl, consecutively, in order to decrease
t h eN a C lc o n c e n t r a t i o n .T h ep r o t e i ni se l u t e di n5  5-ml fractions of Buffer
A containing400 mMimidazoleand100 mMNaCl.Theflowthrough,wash,
andelutionfractionsareanalyzedbySDS–PAGE,andtheproteinisvisualized
by staining the gel with Coomassie blue. Figure 15.2A shows the purification
of an hADAR2 protein construct after the first Ni-NTA column.
An AKTA FPLC system (GE Healthcare) is used to load the eluted
protein onto a 5-ml Hi-Trap heparin column (GE Healthcare) equilibrated
with Buffer A containing 100 mM NaCl. The column is washed with 50 ml
Buffer A containing 100 mM NaCl and eluted with a gradient of 100 mM
to 1 M NaCl in Buffer A. ADAR proteins typically elute between 300 and
500 mM NaCl, and fractions are analyzed by SDS–PAGE. At this stage, the
hADAR2 protein is approximately 85–90% pure (Fig. 15.2B).
The fractions containing the ADAR protein are pooled, and TEV
protease (Invitrogen) is added to cleave the His-tag and TEV recognition
site from the ADAR protein. Typically, 100 units of TEV are used to cleave
5 mg of ADAR, but quantities of TEV added should be optimized empiri-
cally. The entire TEV-ADAR reaction is dialyzed against Buffer A contain-
ing 200 mM NaClovernight at 4 . The following day, the reaction contents
1 If the protein is to be analyzed by mass spectrometry, the Triton X-100 should be omitted, as detergents
strongly interfere with ionization.
2 For smaller-scale preparations, i.e., 1-liter cultures or less, a French pressure cell is used. Other methods for
lysing the yeast, such as sonication and vortexing in glass beads, have been inefficient in our hands, compared
to lysing the cells under high pressure.
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rocking. The slurry is poured into a 2.5   20-cm column and washed with
80 ml of Buffer A with 200 mM NaCl. Uncleaved protein and the cleaved
His-tag (as well as several other contaminants) remain bound to the resin.
The flowthrough and wash (which contain the cleaved ADAR protein) are
concentrated to  1 ml using an Amicon-Ultra 15 centrifugal concentrator
tube with a 30,000 Da molecular weight cut-off. If the majority of the
ADAR remains bound to the resin and is not in the flowthrough or wash, it
is likely the TEV reaction was inefficient. The major factor affecting
cleavage by TEV is the presence of secondary structure at the N-terminus
of the ADAR, which may inhibit recognition of the TEV site. If this is a
problem, the N-terminus should be redesigned to include three glycine
residuesto act asa ‘‘spacer’’between the cleavage siteand the N-terminus of
the ADAR.
The concentrated protein is then injected onto a Superdex 200 26/60 gel
filtration column (GE Healthcare), and eluted with Buffer A containing
200 mM NaCl. One milliliter fractions are collected and analyzed by SDS–
PAGE (Fig. 15.3A). Typically, our hADAR2 protein construct (calculated
MW  76.6 kDa) elutes as a symmetrical peak with a molecular weight of
 100 kDa, relative to a standard curve of proteins of a known size. The
‘‘shoulders’’ of the peak often contain minor contaminants and are discarded.
Themainpeakfractionsarepooled,concentrated,anddialyzedagainststorage
buffer containing 20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 20% glycerol,
and 1 mM 2-mercaptoethanol. We quantify the protein using two methods.
The first is by the Bradford method using a kit available from Bio-Rad; the
second is by SYPRO-Red (Molecular Probes) staining of an SDS–PAGE gel
Ni-NTA Heparin AB
MM FT W1 W2 W3 E1 E2 E3 E4 E5
97
68
45
31
21
14
0.1 M–1 M NaCl
hADAR2
Figure 15.2 SDS^PAGE analysis of the first two purification steps of hADAR2.
(A) The Coomassie blue-stained gel after the first Ni-NTAcolumn.Thelanes from left
to right are molecular weight standard (M), flowthrough (FT), washes 1^3 (W1-W3),
and elution fractions (E1-E5). hADAR2 migrates as a band of 80^90 kDa. (B) The
stained gel containing fractions eluted from a heparin column. Every third fraction
froma0.1to1MNaClelutiongradientisloadedonthegel.
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Figure 15.3 Analysis of hADAR2 purified from S. cerevisiae. (A) A Coomassie blue-stained gel containing every third fraction from the
hADAR2 peakeluted from a Superdex 20026/60 preparative gel filtrationcolumn. (B) TheUVtrace of hADAR2 eluted from a Superdex 200
10/300 analytical gel filtrationcolumn.The elutionvolume of hADAR2 is14.4 ml.The elution peaks ofseveral molecular weight standards areandvisualizationusingaMolecularDynamicsStormPhosphorImager.Yields
of pure protein vary between construct, but typically range from 3 to 10 mg/
liter of original yeast culture. The protein is stored as aliquots at  80 .
3. Analysis of Purified hADAR2
Various ADAR proteins purified using this scheme have been used for
kinetic analyses, RNA binding assays, and X-ray crystallography
(Haudenschild et al., 2004; Macbeth et al., 2004, 2005). Here we present an
analysis of theoligomerization stateofhADAR2,aspurified from S.cerevisiae,
using analytical gel filtration and equilibrium sedimentation.
3.1. Analytical gel filtration
For an analytical gel filtration analysis, 50 ml of purified, concentrated
(6.6 mg/ml) hADAR2 is injected onto a Superdex 200 10/300 gel filtration
column using an AKTA FPLC system (GE Healthcare). The protein was
eluted with 20 mM Tris–HCl (pH 8.0), 200 mM NaCl, 5% glycerol, and
1m M 2-mercaptoethanol, and the elution profile was analyzed with the
PrimeView software package (GE Healthcare, Fig. 15.3B). The elution
volume of the hADAR2 peak was determined to be 14.4 ml. Relative to
the elution of standard molecular weight markers, hADAR2 has an
observed molecular weight of 98.1 kDa and appears to be a monomer
under these conditions (Fig. 15.3B).
3.2. Equilibrium sedimentation
To observe the oligomeric state of hADAR2, equilibrium sedimentation is
performed as it allows an accurate determination of the molecular weight of a
macromolecule that is independent from its shape. Purified hADAR2 was
dialyzed against a buffer containing 20 mM Tris–HCl (pH 8.0), 200 mM
NaCl, and 1 mM 2-mercaptoethanol and diluted to 1.3, 3.3, and 6.6 mM.
The protein was centrifuged in a Beckman XLA analytical ultracentrifuge,
equipped with the AN-60 Ti rotor, at 16,000 and 18,000 rpm. Figure 15.3C
indicated and numbered1^4.Theirsizes and retentionvolumes are (1) aldolase158 kDa,
13.8 ml, (2) albumin 67 kDa,14.7 ml, (3) ovalbumin 43 kDa,15.7 ml, and (4) chymotryp-
sinogen A 25 kDa,17.5 ml.The calculated molecular weight of hADAR2, determined
from a standard curve of the known molecular weight standards, is 98.1 kDa. (C) The
equilibrium sedimentation data for hADAR2 at concentrations of 1.3 (○), 2.6 (△), and
6.6 (þ) mM, respectively.The lower panels are the datafit to a species of MW 75,320 Da.
Theupperpanelsshowtheresidualscorrespondingtoeachfit.
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The best overall fit of the data was to a single species molecule with an
observed molecular weight of 75,320 Da. The residuals are relatively small
and randomly distributed, indicating a good fit of the data. The MWobs/
MWcalc is 0.98, suggesting hADAR2 exists as a monomer under these
concentrations.
4. Future Perspectives
We have developed an overexpression protocol and rapid purification
scheme to generate ADAR protein that is untagged and contains native
sequenceexceptforanN-terminalglycine.Theproteinis>99%pure,exists
as a single species, and is highly active in deaminating dsRNA. The protein
purified using this system can be used for many biophysical and structural
studies (such as calorimetry, crystallography, and single turnover kinetics)
that require large amounts of pure protein.
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